Cell Biology – Immunology – Pathology

Kidney International (2004) 65, 490–499; doi:10.1111/j.1523-1755.2004.00413.x

Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha

GANESAN RAMESH and W BRIAN REEVES

Division of Nephrology, The Penn State College of Medicine, Hershey, Pennsylvania; and Lebanon VA Medical Center, Lebanon, Pennsylvania

Correspondence: W. Brian Reeves M.D., Division of Nephrology, H040, Penn State College of Medicine, 500 University Dr., Hershey, PA 17033. E-mail:Wreeves@psu.edu

Received 10 April 2003; Revised 24 July 2003; Re-revised 30 August 2003; Accepted 22 September 2003.

Top

Abstract

Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha.

Background

 

Salicylate was recently shown to provide protection against cisplatin nephrotoxicity in rats. We have demonstrated that enhanced tumor necrosis factor-alpha (TNF-alpha) production mediates, in part, cisplatin nephrotoxicity. The purpose of this study was to determine if the protective effects of salicylate were mediated through inhibition of TNF-alpha in vivo and to explore the mechanism of inhibition in vitro.

Methods

 

The effects of treatment with cisplatin alone and in combination with sodium salicylate in mice on renal function, histology, and gene expression were determined. The effects of cisplatin and salicylate on TNF-alpha expression, nuclear factor kappa B (NF-kappaB) activity, and apoptosis were determined in vitro using cultured murine proximal tubule cells.

Results

 

Salicylate significantly reduced both the functional and histologic evidence of cisplatin renal injury. Cisplatin increased the renal expression of TNF-alpha, monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion molecule (ICAM)-1, heme oxygenase-1, TNF receptor 1 (TNFR1), and TNF receptor 2 (TNFR2). Treatment with sodium salicylate blunted the increase in TNF-alpha mRNA and also reduced serum TNF-alpha protein levels. Salicylate had little protective effect when administered with cisplatin to TNF-alpha–deficient mice. Cisplatin increased the degradation of I kappa B (IkappaB) in a time-dependent manner and also increased nuclear NF-kappaB binding activity. Salicylate inhibited IkappaB degradation and NF-kappaB binding activity in the presence of cisplatin. In addition, salicylate inhibited the cisplatin induced TNF-alpha mRNA increase in mouse proximal tubule epithelial (TKPT) cells.

Conclusion

 

These results indicate that salicylate acts via inhibition of TNF-alpha production to reduce cisplatin nephrotoxicity. The inhibition of TNF-alpha production may be mediated via stabilization of IkappaB.

Keywords:

acute tubular necrosis, gene expression, IkappaB, NF-kappaB, tumor necrosis factor receptor, cytokines

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

Janus faces of NF-κB: Neurodestruction versus neuroprotection

Nature Medicine News and Views (01 Jan 1997)

Extra navigation

.
ADVERTISEMENT